Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon/Rectal Cancer Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04758195
What this trial is testing

Transanal Irrigation to Prevent Major Low Anterior Resection Syndrome

Who this might be right for
Low Anterior Resection Syndrome
Sixth Affiliated Hospital, Sun Yat-sen University 100
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654131
What this trial is testing

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Who this might be right for
Colorectal CarcinomaLiver Metastases
Rigshospitalet, Denmark 100
Not applicableUnknownNCT01754272
What this trial is testing

A Non-Interventional Follow-Up to the VELOUR Study - Translational Research

Who this might be right for
Metastatic Colorectal Cancer
KU Leuven 1,226
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableActive Not RecruitingNCT02078804
What this trial is testing

Colonoscopy and FIT as Colorectal Cancer Screening Test in the Average Risk Population

Who this might be right for
Colorectal Cancer
Uppsala University Hospital 278,000
Large-scale testing (Phase 3)Study completedNCT00126256
What this trial is testing

Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastasis
Gustave Roussy, Cancer Campus, Grand Paris 570
Early research (Phase 1)Study completedNCT00603356
What this trial is testing

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Not applicableNot Yet RecruitingNCT07254156
What this trial is testing

Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer

Who this might be right for
Colorectal CancerMRDctDNA
Sun Yat-sen University 229
Not applicableNot Yet RecruitingNCT07398456
What this trial is testing

Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas

Who this might be right for
Colorectal Cancer (CRC) Screening
Baylor Research Institute 5,500
Not applicableLooking for participantsNCT06314022
What this trial is testing

A Mobile Application to Improve the Quality of Colonoscopy in Colorectal Cancer Screening Program (PrepColon APP)

Who this might be right for
Colorectal CancerPremalignant Colon Lesions
Hospital del Rio Hortega 470
Not applicableStudy completedNCT04449822
What this trial is testing

Emergency Surgery Versus Colorectal Stents for the Management of Malignant Colonic Obstructions

Who this might be right for
Colorectal Cancer
Zaza Demetrashvili 40
Testing effectiveness (Phase 2)Study completedNCT04216251
What this trial is testing

PRevention Using EPA Against coloREctal Cancer

Who this might be right for
Colorectal AdenomaColorectal CancerEndoscopic Surgery+2 more
Massachusetts General Hospital 81
Testing effectiveness (Phase 2)Study completedNCT00630786
What this trial is testing

Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+2 more
Amgen 53
Testing effectiveness (Phase 2)Study completedNCT03206073
What this trial is testing

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00625573
What this trial is testing

Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)

Who this might be right for
Colorectal Cancer
Mt. Sinai Medical Center, Miami 29
Testing effectiveness (Phase 2)UnknownNCT03073694
What this trial is testing

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

Who this might be right for
Cancer, AppendicealColoRectal Cancer
University of Kansas Medical Center 100
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Early research (Phase 1)UnknownNCT05213195
What this trial is testing

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
Zhejiang University 38
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Next Page